Disease Databases atabases
  • Succinic Semialdehyde Dehydrogenase Deficiency(SSADH) Database
  • Dopamine Related Disease Database
  • Succinic Semialdehyde Dehydrogenase Deficiency(SSADH) Database
Phillip L. Pearl M.D. is a child neurologist at Children's National Medical Center, Washington D.C., Associate Professor of Pediatrics and Neurology at the George Washington University School of Medicine and is a member of the PND Medical and Scientific Advisory Board. Dr. Pearl works closely with K. Michael Gibson PhD, Director Biochemical Genetics Laboratory, Oregon Health Sciences University and has been instrumental in diagnosing and treating children with SSADH. Recently Dr. Pearl has initiated the development of a clinical database for patients with SSADH.

The goal of the database is to create a central source for clinical information on patients with SSADH. This information will provide clinicians and investigators with important data such as patient history, signs and symptoms, treatments and standards of care. Presently there is no central source for this data and it is imperative that this information be available to assist with the investigation of future treatment modalities.

Participation is entirely voluntary and anonymous. Any information obtained from the database will be done in an anonymous fashion in order to protect the confidentiality of patients and families.

If you would like to participate in the database or would like further information about this effort please contact:

Phillip L. Pearl M.D.
Department of Neurology
Children's National Medical Center
111 Michigan Avenue, NW
Washington, D.C. 20010-2970
Phone: (202) 884-2120
Fax: (202) 884-5226
E-mail: [email protected]


For a copy of an SSADH database questionnaire you can email [email protected]

 

  • Dopamine Related Disease Database
Dr. Kathyrn Swoboda, M.D. is a clinical geneticist and neurologist at the University of Utah School of Medicine and Primary Children's Medical Center. Dr. Swoboda has been instrumental in diagnosing and treating children with pediatric neurotransmitter diseases. Recently she has designed and implemented a clinical and genetic relational database for patients with dopamine related neurotransmitter disorders. She has designed a clinical questionnaire for families and is in the process of designing an additional one for physicians.

The goal is to correlate the information obtained from physicians and families with CSF neurotransmitter results. Hopefully, with the information gathered from the questionnaires, additional insights will be obtained about the signs and symptoms of pediatric neurotransmitter diseases and the medications that are being used to treat them.

Also as part of this project, Dr. Swoboda would like to begin collection of blood samples for DNA extraction and permanent cell lines on all patients, their parents and one unaffected sibling if possible in order to facilitate additional studies. Having a repository of such samples in one place along with cell lines for a permanent source of DNA will facilitate research efforts on PND's.

Participation is entirely voluntary and anonymous. Any information obtained from the database will be done in an anonymous fashion, in order to protect the confidentiality of patients and families.

For further information about the database please contact:

Kathryn Swoboda M.D.
Primary Children's Medical Center
100 North Medical Drive
Salt Lake City, Utah 84132
Phone: (801) 585-9717
E-mail: Mark Wride [email protected]


For a copy of the Dopamine database questionnaire you can email [email protected]

2003 Pediatric Neurotransmitter Disease Association

www.pndassoc.org